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Interventional atrial incision in the
Fontan operation: Novel prophylaxis
or iatrogenic substrate for intra-
atrial reentrant tachycardia?
To the Editor:
In the March 2004 issue of the Journal,
Collins and colleagues1 published short-
term results of their interesting prospective,
randomized, blinded trial to assess the fea-
sibility, safety, and efficacy of an interven-
tional atrial incision placed at the time of
the Fontan operation to reduce the devel-
opment of intra-atrial reentrant tachycardia
(IART). Although the idea sounds clever,
there are serious concerns about the long-
term efficacy of their modification.
Staged palliation culminating in a suc-
cessful Fontan procedure is the current
surgical goal for most patients with a func-
tional single ventricle. Since its introduc-
tion in 1968, the Fontan procedure has un-
dergone many modifications.2 At present,
two modifications in common use are the
lateral tunnel and extracardiac conduit.3
The incidence of late supraventricular
tachycardia after a lateral tunnel procedure
varies from 0% to 22%, and that after an
extracardiac conduit operation varies from
0% to 8%.3 These figures definitely do not
justify undertaking a prophylactic proce-
dure for IART in all patients who undergo
Fontan operation in the modern era. It is
extremely difficult to predict with accuracy
the patients who will definitely have IART.
An even more important concern is the
high incidence of early sinus node dysfunc-
tion among the study patients. Early sinus
node dysfunction may carry long-term im-
plications because it predicts late sinus
node dysfunction,4 which in turn is associ-
ated with late supraventricular tachycar-
dia.5 Although Collins and colleagues1 at-
tributed this high incidence to a “broad
definition” of sinus node dysfunction, I
think that the interventional atrial incision
may be partially if not wholly responsible
for this phenomenon. There is a consensus
of opinion that the presence of a region of
structural or functional block within the
atria is a substrate for atrial muscle reen-
try.5 The Fontan operation results in re-
gions of structural block as a result of atrial
incisions and multiple suture lines, as well
as functional block from relative right atrial
hypertension with right atrial dilation and
hypertrophy.5 The “prophylactic atrial in-
cision” not only will act as region of struc-
tural block in the long term but probably
interferes with the blood supply of the si-
nus node in the short term. This could well
explain the high incidence of early sinus
node dysfunction in the study.
In conclusion, the high prevalence of
atrial arrhythmias is a result of extensive
atrial surgical procedures, elevated atrial
pressures, and atrial enlargement. Until
modifications aimed at avoiding atrial ma-
nipulation are discovered, earlier identifi-
cation of sinus node dysfunction with early
institution of atrial pacing may be the best
prophylaxis to decrease the incidence of
IART in this group of patients. My mes-
sage for Collins and colleagues in particu-
lar and readers in general is that any “pro-
phylactic atrial incision” made with the
best of intentions will act as nothing but a
substrate for IART.
Shahzad G. Raja, MRCS
Department of Paediatric Cardiac Surgery
Alder Hey Hospital
Eaton Rd
Liverpool L12 2AP, United Kingdom
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Reply to the Editor:
The Fontan population is heterogeneous in
terms of the underlying anatomy and num-
ber and nature of surgical interventions be-
fore the Fontan operation. Many factors are
thought to be associated with the develop-
ment of atrial arrhythmias in this group.
Animal studies have suggested that surgi-
cal incision and extended suture lines are
particularly likely to create an arrhythmo-
genic substrate.1-3 The more recent ver-
sions of the Fontan procedure (lateral tun-
nel or the extracardiac conduit) have had
lower reported incidences of late atrial ar-
rhythmias than the older types of Fontan
operations.4 Long-term follow-up of the
extracardiac conduit Fontan operation has
not yet been reported with respect to ar-
rhythmia, but Stamm and colleagues4 have
recently shown that the lower incidence of
atrial tachycardia in the lateral tunnel Fon-
tan procedure persisted through a mean 10-
year follow-up.4 One can interpret this
finding to mean that the current Fontan
techniques are in fact less arrhythmogenic
then was initially projected when our study
was undertaken. If so, placement of an in-
terventional atrial incision to the lateral
tunnel Fontan may not be warranted in
every case, only for patients deemed at
higher risk (eg, with a preoperative history
of atrial tachycardia).
Although avoiding atrial manipulation
and suture lines altogether has theoretic
benefits, it is not practical in all cases. If
atrial suture lines are required for the sur-
gical intervention, then choosing to place
or extend them in such a way to reduce the
likelihood of atrial arrhythmias is war-
ranted. Our interventional atrial incision to
the lateral tunnel Fontan procedure was
designed to transect potential arrhythmia
circuits around the atriotomy or the right
atrioventricular valve, the primary areas
where atrial arrhythmias typically develop.
It was designed to be simple, to be feasible
in patients with varied anatomy, and to
have low added risks for the patient. The
location of the incision is inferior to the
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sinus node or the blood supply to the sinus
node. The interventional incision will not
act as a substrate for atrial arrhythmias
because there is no atrial tissue surrounding
the incision around which a tachycardia
circuit could propagate; the incision is an-
chored on either end by the nonconducting
boundaries of the atriotomy and the right
atrioventricular annulus. In fact, treatment
of atrial arrhythmias by the Fontan revision
surgeries with the right atrial maze proce-
dures are designed create conduction block
by similar but more extensive means.5
I agree that early postoperative sinus
node dysfunction is associated with the de-
velopment of late sinus node dysfunction
and late atrial tachyarrhythmias. In our
clinical trial, we reported a high percentage
of early sinus node dysfunction in both the
control and intervention groups, with no
statistically significant difference between
the two groups. Thus the sinus node dys-
function seen in this study was not attrib-
utable to the interventional atrial incision.
Our study reported only the short-term
outcomes of our interventional atrial inci-
sion for the prevention of intra-atrial reen-
trant tachycardia in the lateral tunnel Fon-
tan population. We have learned that, in
contrast to previous clinical and animal
studies, inducible perioperative atrial ar-
rhythmias were not especially common
clinically in these patients. Following up
our cohort to assess long-term arrhythmia
prevalence will provide a useful addition to
our knowledge of the arrhythmia substrate
in the Fontan population.
Kathryn K. Collins, MD
University of California, San Francisco
521 Parnassus, C-346, Box 0632
San Francisco, CA 94117
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Ventral cardiac denervation: Is it
truly an effective prophylaxis against
atrial fibrillation after coronary
artery bypass grafting?
To the Editor:
We read with interest the article by Melo
and colleagues1 on ventral cardiac dener-
vation (VCD) as a prophylaxis against
atrial fibrillation (AF) after coronary revas-
cularization. However, we wish to point
out certain aspects of the methodology that
may have affected the results. Post-CABG
AF is paroxysmal in a large proportion of
patients and does not always give rise to
clinical symptoms. The fact that only 34%
and 33% of the patients in their VCD and
control groups, respectively, had continu-
ous telemetry monitoring for 4 days would
have significantly reduced the AF detection
rate, the primary end point of the study.
Although statistically nonsignificant, the
mixture of different myocardial preserva-
tion strategies used (crystalloid cardiople-
gia, blood cardioplegia, and off-pump) ef-
fectively reduced the advantage of the large
number of patients in the study.
We conducted a study between January
2002 and April 2003 (Table 1) in which we
compared the incidence of AF among 70
consecutive patients undergoing primary
CABG with that among 70 consecutive pa-
tients who underwent VCD (with the same
technique described by Melo and col-
leagues1) in addition to primary CABG.
All patients were operated by the same
consultant surgeon with the same bypass
method and myocardial preservation tech-
nique (antegrade-retrograde cold St
Thomas’ Hospital blood cardioplegia). All
patients had continuous telemetry monitor-
ing for 5 days after the operation. In con-
TABLE 1. Data and outcome after ventral cardiac denervation in patients un-
dergoing CABG with or without VCD
Preoperative variables
VCD
(n  70)
No VCD
(n  70) P value
Age (y, mean  SD) 65 10 65 9 .7
Sex (M/F) 5:1 6:1 .6
Disease severity (%) .8
Single vessel 1% 3%
Double vessel 23% 22%
Triple vessel 76% 75%
Left ventricular function (%) .5
50% 76% 80%
50%–30% 17% 16%
 30% 7% 4%
Myocardial infarction (%) .8
Never 69% 71%
30 d 28% 25%
1–30 d 3% 4%
Diabetes 16% 13% .6
Hypertension (%) 65% 57% .4
Chronic obstructive airway disease (%) 10% 11% .8
Parsonnet score (mean  SD) 7.1 5.5 6.8 6.5 .9
EuroSCORE (mean  SD) 2.5 1.7 2.3 1.7 .6
-Blockers (%) 69% 72% .4
Crossclamp time (min, mean  SD) 34.3 7.5 33.4 7.5 .6
Bypass time (min, mean  SD) 57 13.5 54 12.2 .1
No. of grafts (mean  SD) 2.8 2.9 .9
Postoperative inotropes (%) 13% 8% .4
Reoperation (%) 1.4% 1.4% .999
Total blood loss (mL, mean  SD) 603 299 648 412 .6
Length of stay (d, mean  SD) 7 0.8 7.5 1.2 .8
AF (%) 29% 34% .3
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